1.
Effects of cacao liquor proanthocyanidins on PhIP-induced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague–Dawley rats
by Yamagishi, Megumi
Cancer letters, 2002, Vol.185 (2), p.123-130

2.
Inhibition of TPA-induced tumor promotion in CD-1 mouse epidermis by a polyphenolic fraction from grape seeds
by Bomser, J.A
Cancer letters, 1999, Vol.135 (2), p.151-157

3.
Protective effects of green tea polyphenols administered by oral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/J mice
by Katiyar, Santosh K
Cancer letters, 1993, Vol.73 (2), p.167-172

4.
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
by Roviello, Giandomenico
Cancer letters, 2016, Vol.372 (2), p.187-191

5.
Estrogen receptor beta as target for colorectal cancer prevention
by Williams, Cecilia
Cancer letters, 2015, Vol.372 (1), p.48-56

6.

7.
Cannabinoids in the treatment of cancer
by Alexander, Amy
Cancer letters, 2009, Vol.285 (1), p.6-12

8.
Tailored therapeutic strategies for synovial sarcoma: Receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001
by Yasui, Hirohiko
Cancer letters, 2014, Vol.347 (1), p.114-122

9.
The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways
by Mancuso, Mariateresa
Cancer letters, 2011, Vol.308 (2), p.197-202

10.
Interplay between estrogen and retinoid signaling in breast cancer – Current and future perspectives
by Ribeiro, Mariana P.C
Cancer letters, 2014, Vol.353 (1), p.17-24

11.
Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organ carcinogenesis model
by Yamagishi, Megumi
Cancer letters, 2003, Vol.191 (1), p.49-57

12.
Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo
by Li, Jing
Cancer letters, 2009, Vol.279 (2), p.213-220
